Composition and Biological Activity of Different Extracts from Schisandra sphenanthera and Schisandra chinensis

Abstract

Plants of the Schisandraceae family contain a variety of pharmacologically active lignans like schizandrin, deoxyschizandrin, deangeloylgomisin B, gomisin A, gomisin O, γ-schizandrin and isogomisin O. Here we have compared the composition of different polar and non-polar extracts of Schisandra sphenanthera and Schisandra chinensis. We also have screened the extracts for antiproliferative and anti-inflammatory effects in different cell-based and cell-free assays. Extracts produced with the non-polar solvents CO₂, hexane and CO₂/5 % ethanol had a similar composition. In contrast, polar extraction with ethanol provided a considerably higher yield, but a lower content of volatiles and lignans in comparison to the non-polar extracts. The proliferation of the epidermal cell lines HaCaT and A431 was dose-dependently inhibited by both the Schisandra sphenanthera and Schisandra chinensis extracts, the non-polar extracts being superior to the polar ones. The non-polar Schisandra sphenanthera extract was the most active with a half-maximal inhibitory concentration of 20 μg/mL. In a cell-free enzyme inhibition assay with recombinant cyclooxygenase-2 (COX-2) the non-polar Schisandra sphenanthera extract dose-dependently inhibited COX-2 catalysed prostaglandin (PG) production (IC₅₀ = 0.2 μg/mL). It also reduced the ultraviolet-B (UVB)-induced PGE₂ production (IC₅₀ = 4 μg/mL) and COX-2 expression in HaCaT keratinocytes. We conclude that non-polar Schisandra extracts obtained by CO₂ extraction might be useful in the prevention and treatment of hyperproliferative and inflammatory skin diseases.

Key words

Schisandra sphenanthera - Schisandra chinensis - lignans - schizandrins - Schisandraceae - cyclooxygenase-2 - ultraviolet-B - skin cancer

References

• 1 Stöger E A. Arzneibuch der Chinesischen Medizin, 6. Ergänzungslieferung 9/1997. Stuttgart; Deutscher Apotheker Verlag 1998.
• 2 Opletal L, Sovova H, Bartlova M. Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination.  J Chromatogr B. 2004;  812 357-71.
• 3 Liu G T. Pharmacological actions and clinical use of Fructus Schizandrae.  Chin Med J (Engl). 1989;  102 740-9.
• 4 Ip S P, Poon M K, Wu S S, Che C T, Ng K H, Kong Y C. et al . Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity.  Planta Med. 1995;  61 398-401.
• 5 Pan S Y, Han Y F, Carlier P R, Pang Y P, Mak D H, Lam B Y. et al . Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice.  Planta Med. 2002;  68 217-20.
• 6 Chiu P Y, Mak D H, Poon M K, Ko K M. In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin.  Planta Med. 2002;  68 951-6.
• 7 Wu M D, Huang R L, Kuo L M, Hung C C, Ong C W, Kuo Y H. The anti-HBsAg (human type B hepatitis, surface antigen) and anti-HBeAg (human type B hepatitis, e antigen) C18 dibenzocyclooctadiene lignans from Kadsura matsudai and Schizandra arisanensis .  Chem Pharm Bull. 2003;  51 1233-6.
• 8 Mu Y, Zhang J, Zhang S, Zhou H H, Toma D, Ren S. et al . Traditional chinese medicines Wu Wei Zi (Schisandra chinensis Baill.) and Gan Cao (Glycyrrhiza uralensis Fisch.) activate PXR and increase warfarin clearance in rats.  J Pharmacol Exp Ther. 2005;  316 1369-77.
• 9 Chen D F, Zhang S X, Wang H K, Zhang S Y, Sun Q Z, Cosentino L M. et al . Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba .  J Nat Prod. 1999;  62 94-7.
• 10 Li R T, Han Q B, Zheng Y T, Wang R R, Yang L M, Lu Y. et al . Structure and anti-HIV activity of micrandilactones B and C, new nortriterpenoids possessing a unique skeleton from Schisandra micrantha .  Chem Commun (Camb). 2005;  23 2936-8.
• 11 Xiao W L, Tian R R, Pu J X, Li X, Wu L, Lu Y. et al . Triterpenoids from Schisandra lancifolia with anti-HIV-1 activity.  J Nat Prod. 2006;  69 277-9.
• 12 Lee I S, Lee H K, Dat N T, Lee M S, Kim J W, Na D S. et al . Lignans with inhibitory activity against NFAT transcription from Schisandra chinensis .  Planta Med. 2003;  69 63-4.
• 13 Chen Y G, Wu Z C, Lv Y P, Gui S H, Wen J, Liao X R. et al . Triterpenoids from Schisandra henryi with cytotoxic effect on leukemia and Hela cells in vitro .  Arch Pharm Res. 2003;  26 912-6.
• 14 Chen Y G, Wu Z C, Gui S H, Lv Y P, Liao X R, Halaweish F. Lignans from Schisandra henryi with DNA cleaving activity and cytotoxic effect on leukemia and Hela cells in vitro .  Fitoterapia. 2005;  76 370-3.
• 15 Yasukawa K, Ikeya Y, Mitsuhashi H, Iwasaki M, Aburada M, Nakagawa S. et al . Gomisin A inhibits tumor promotion by 12-O-tetradecanoylphorbol 13-acetate in two-stage carcinogenesis in mouse skin.  Oncology. 1992;  49 68-71.
• 16 Ohkura Y, Mizoguchi Y, Morisawa S, Takeda S, Aburada M, Hosoya E. Effect of gomisin A (TJN-101) on the arachidonic acid cascade in macrophages.  Jpn J Pharmacol. 1990;  52 331-6.
• 17 Yang S B. Study on supercritical CO₂ fluid extract and separation of components from fruits of Schisandra sphenanthera .  Zhongguo Zhong Yao Za Zhi. 2001;  26 755-7.
• 18 Popov I, Lewin G. Photochemiluminescent detection of antiradical activity. VII. Comparison with a modified method of thermo-initiated free radical generation with chemiluminescent detection.  Luminescence.. 2005;  20 21-5.
• 19 Schempp C M, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer C C. et al . Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John’s wort that acts by induction of apoptosis.  Oncogene. 2002;  21 1242-50.
• 20 Schempp C M, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, Kremer B. et al . Hyperforin acts as an angiogenesis inhibitor in vitro and in vivo .  Planta Med. 2005;  71 999-1004.
• 21 Jocher A, Kessler S, Hornstein S, Schulte Mönting J, Schempp C M. The UV-erythema test as a model to investigate the anti-inflammatory potency of topical preparations. Re-evaluation and optimization of the method.  Skin Pharmacol Physiol. 2005;  18 234-40.
• 22 Laszczyk M, Jager S, Simon-Haarhaus B, Scheffler A, Schempp C M. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex).  Planta Med. 2006;  72 1389-95.
• 23 Brock T G, McNish R W, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E₂ .  J Biol Chem. 1999;  274 11 660-6.
• 24 Danz H, Stoyanova S, Wippich P, Brattstrom A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria .  Planta Med. 2001;  67 411-6.
• 25 Danz H, Stoyanova S, Thomet O A, Simon H U, Dannhardt G, Ulbrich H. et al . Inhibitory activity of tryptanthrin on prostaglandin and leukotrienee synthesis.  Planta Med. 2002;  68 875-80.
• 26 Isoherranen K, Punnonen K, Jansen C, Uotila P. Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes.  Br J Dermatol. 1999;  140 1017-22.
• 27 Müller-Decker K. Cyclooxygenases in the skin.  J Dtsch Dermatol Ges. 2004;  2 668-75.
• 28 Anderson G D, Hauser S D, McGarity K L, Bremer M E, Isakson P C, Gregory S A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.  J Clin Invest. 1996;  97 672-9.
• 29 Buckman S Y, Gresham A, Hale P, Hruza G, Anast J, Masferrer J. et al . COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer.  Carcinogenesis. 1998;  19 723-9.
• 30 Hamburger M, Baumann D, Adler S. Supercritical carbon dioxide extraction of selected medicinal plants - effects of high pressure and added ethanol on yield of extracted substances.  Phytochem Anal. 2004;  15 46-54.